Lisitril comp. 20/12.5
Lisitril comp. 20/12.5 is a medicine authorised by Swissmedic under authorisation number 56748. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 November 2004 and the authorisation is valid without a time limit. ATC code C09BA03 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 56748 |
|---|---|
| Name | Lisitril comp. 20/12.5 |
| Full name | Lisitril comp. 20/12.5, Tabletten |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09BA03 |
| First authorisation | 08 November 2004 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lisitril comp. 20/12.5, Tabletten | B | 08 November 2004 |
| 2 | Lisitril comp. 10/12.5, Tabletten | B | 08 November 2004 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 5 | 30 | Tablette(n) | C09BA03 | 02.07.2. | B |
| 7 | 100 | Tablette(n) | C09BA03 | 02.07.2. | B |
| 1 | 30 | Tablette(n) | C09BA03 | 02.07.2. | B |
| 3 | 100 | Tablette(n) | C09BA03 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lisitril comp. 20/12.5 authorised in Switzerland?
Yes. Lisitril comp. 20/12.5 is authorised by Swissmedic under authorisation number 56748, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lisitril comp. 20/12.5 have?
Lisitril comp. 20/12.5 is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lisitril comp. 20/12.5?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.